Immunoregulation in Autoimmune Thyroid Disease
- 1 January 1987
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 316 (1) , 44-46
- https://doi.org/10.1056/nejm198701013160109
Abstract
Times change. This trite but apt phrase can safely be applied to the study of autoimmune thyroid diseases, including Graves' disease and Hashimoto's thyroiditis and its variants, to reflect the remarkable progress made during the past three decades. This period began in 1956 with the seminal discoveries of thyroid antibodies by Roitt and Doniach, of experimental autoimmune thyroiditis by Rose and Witebsky, and of an abnormal thyroid stimulator in Graves' disease by Adams and Purves.1 In 1972 I contributed an editorial to the Journal 2 in which I indicated that cell-mediated immunity had then been demonstrated in Graves' disease and further . . .Keywords
This publication has 9 references indexed in Scilit:
- Induction of Circulating Activated Suppressor-like T Cells by Methimazole Therapy for Graves' DiseaseNew England Journal of Medicine, 1987
- EVIDENCE THAT ANTITHYROID DRUGS INDUCE REMISSIONS IN GRAVEs' DISEASE BY MODULATING THYROID CELLULAR ACTIVITYClinical Endocrinology, 1986
- Thyrocyte HLA-DR Expression and Interferon-?Production in Autoimmune Thyroid Disease*Journal of Clinical Endocrinology & Metabolism, 1986
- Immune Mechanisms In Graves' DiseaseEndocrine Reviews, 1985
- Autoimmune Thyroid Disease: Developments in Our UnderstandingEndocrine Reviews, 1984
- ROLE OF ABERRANT HLA-DR EXPRESSION AND ANTIGEN PRESENTATION IN INDUCTION OF ENDOCRINE AUTOIMMUNITYThe Lancet, 1983
- Immunology of Autoimmune Thyroid DiseasesNew England Journal of Medicine, 1982
- The Immunologic Basis of Graves's DiseaseNew England Journal of Medicine, 1972
- Immunoglobulins (E, M, G) and Complement in the Connective Tissues of the Thyroid in Graves's DiseaseNew England Journal of Medicine, 1972